Florida Cancer Specialists

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 24 trials
• Phase 31 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Pfizer3 trials
• Seagen, a wholly owned subsidiary of Pfizer2 trials

Running trials

• Recruiting

  A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  NCT04879329· Phase 2· Seagen, a wholly owned subsidiary of Pfizer· Source

• Active, not recruiting

  Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

  NCT04404283· Phase 3· Seagen, a wholly owned subsidiary of Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer1 recruiting

Closed trials

• Completed

  An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

  NCT03915951· Phase 2· Pfizer· Source

• Completed

  Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

  NCT02007512· Phase 2· Pfizer· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

  NCT01889238· Phase 2· Pfizer· Source